American Portfolios Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

American Portfolios Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-110	Closed	-$8.48K	–	3419
2021 Q1	$8.48K	Buy	110 +7	+7%	+$645	﹤0.01%	2457
2020 Q4	$10.2K	Hold	103	–	–	﹤0.01%	2099
2020 Q3	$14.6K	Buy	103 +70	+212%	+$11.7K	﹤0.01%	1838
2020 Q2	$6.51K	Hold	33	–	–	﹤0.01%	2119
2020 Q1	$6.46K	Sell	33 -3	-8%	-$645	﹤0.01%	1992
2019 Q4	$7.45K	Hold	36	–	–	﹤0.01%	2117
2019 Q3	$5.5K	Buy	+36	New	+$5.9K	﹤0.01%	2166
2018 Q1	–	Sell	-5	Closed	-$469	–	2343
2017 Q4	$469	Buy	+5	New	+$473	﹤0.01%	2199

Other funds holding LKFT

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

American Portfolios Advisors's LKFT Position: Q2 2021 in Review

American Portfolios Advisors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 110 shares — an estimated $8.48K sold.

American Portfolios Advisors first reported a position in LKFT in Q4 2017 and held it in 8 quarters. The position peaked at $14.6K in Q3 2020. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

American Portfolios Advisors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
American Portfolios Advisors sold 110 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $8.48K.
American Portfolios Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2017 and held it in 8 quarters.
American Portfolios Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $14.6K in Q3 2020.
108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on American Portfolios Advisors's 13F filing for Q2 2021, filed 22 Mar 2023.